Filing Details

Accession Number:
0001437749-13-015656
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-04 17:59:36
Reporting Period:
2013-12-02
Filing Date:
2013-12-04
Accepted Time:
2013-12-04 17:59:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389545 Novabay Pharmaceuticals Inc. NBY Pharmaceutical Preparations (2834) 680454536
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1593301 Pioneer Pharma (Hong Kong) Co Ltd Flat 2605, 26/F Trendy Centre
682 Castle Peak Road
Lai Chi Kok, Kowloon, Hk
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-02 5,000,000 $1.14 7,005,656 No 4 P Indirect By Pioneer Pharma (Singapore) Pte. Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Pioneer Pharma (Singapore) Pte. Ltd.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant (Right to Buy) Disposition 2013-12-02 800,000 $0.00 800,000 $1.50
Common Stock Common Stock Purchase Warrant (Right to Buy) Disposition 2013-12-02 1,200,000 $0.00 1,200,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-09-13 2013-11-29 No 4 H Indirect
0 2012-11-01 2013-11-29 No 4 H Indirect
Footnotes
  1. The shares and warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., which is a wholly owned subsidiary of the Reporting Person.